Kết quả tìm kiếm - Vanitha Ramakrishnan

  • Đang hiển thị 1 - 15 kết quả của 15
Tinh chỉnh kết quả
  1. 1
    The Proteinase-activated Receptor 2 Is Induced by Inflammatory Mediators in Human Endothelial Cells

    The Proteinase-activated Receptor 2 Is Induced by Inflammatory Mediators in Human Endothelial Cells Bằng Sverker Nystedt, Vanitha Ramakrishnan, Johan Sundelin

    Được phát hành 1996
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  2. 2
    A thrombin receptor function for platelet glycoprotein Ib–IX unmasked by cleavage of glycoprotein V

    A thrombin receptor function for platelet glycoprotein Ib–IX unmasked by cleavage of glycoprotein V Bằng Vanitha Ramakrishnan, Francis DeGuzman, Ming Bao, Scott W. Hall, Lawrence Leung, David R. Phillips

    Được phát hành 2001
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  3. 3
    Increased thrombin responsiveness in platelets from mice lacking glycoprotein V

    Increased thrombin responsiveness in platelets from mice lacking glycoprotein V Bằng Vanitha Ramakrishnan, Peter S. Reeves, Francis DeGuzman, Usha Deshpande, Kathleen Ministri-Madrid, Robert B. DuBridge, David R. Phillips

    Được phát hành 1999
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  4. 4
    A function blocking anti-mouse integrin α5β1 antibody inhibits angiogenesis and impedes tumor growth in vivo

    A function blocking anti-mouse integrin α5β1 antibody inhibits angiogenesis and impedes tumor growth in vivo Bằng Vinay Bhaskar, Dong Zhang, Melvin Fox, Pui Seto, Melanie Wong, Pauline Wales, David B. Powers, Debra T. Chao, Robert B. DuBridge, Vanitha Ramakrishnan

    Được phát hành 2007
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  5. 5
    Molecular associations of response to the new-generation BTK inhibitor zanubrutinib in marginal zone lymphoma

    Molecular associations of response to the new-generation BTK inhibitor zanubrutinib in marginal zone lymphoma Bằng Maciej Tatarczuch, Mark Waltham, Jake Shortt, Galina Polekhina, Eliza A. Hawkes, Shir‐Jing Ho, Judith Trotman, Daniella Brasacchio, Melannie Co, Jessica Li, Vanitha Ramakrishnan, Karin Dunne, Stephen Opat, Gareth P. Gregory

    Được phát hành 2023
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  6. 6
    Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via α5-Integrin, which Is a Therapeutic Target

    Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via α5-Integrin, which Is a Therapeutic Target Bằng Kenjiro Sawada, Anirban K. Mitra, A. Reza Radjabi, Vinay Bhaskar, Emily O. Kistner, Maria Tretiakova, Sujatha Jagadeeswaran, Anthony Montag, Amy R. Becker, Hilary A. Kenny, Marcus E. Peter, Vanitha Ramakrishnan, S. Diane Yamada, Ernst Lengyel

    Được phát hành 2008
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  7. 7
    Antibodies to TWEAK Receptor Inhibit Human Tumor Growth through Dual Mechanisms

    Antibodies to TWEAK Receptor Inhibit Human Tumor Growth through Dual Mechanisms Bằng Patricia Culp, Donghee Choi, Yongke Zhang, Johnny Yin, Pui Seto, Suzanne E. Ybarra, Mian Su, Mien Sho, Roxanne Steinle, Melanie Wong, Ferdinand Evangelista, Jennifer Grove, Marie Cardenas, Marjorie James, Eric D. Hsi, Debra T. Chao, David B. Powers, Vanitha Ramakrishnan, Robert B. DuBridge

    Được phát hành 2010
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  8. 8
    Evaluation and Clinical Analyses of Downstream Targets of the Akt Inhibitor GDC-0068

    Evaluation and Clinical Analyses of Downstream Targets of the Akt Inhibitor GDC-0068 Bằng Yibing Yan, Violeta Serra, Ludmila Prudkin, Maurizio Scaltriti, Sumati Murli, Olga Rodríguez, Marta Guzmán, Deepak Sampath, Michelle Nannini, Yuanyuan Xiao, Marie-Claire Wagle, Jenny Wu, Matthew Wongchenko, Garret M. Hampton, Vanitha Ramakrishnan, Mark R. Lackner, Cristina Saura, Desamparados Roda, Andrés Cervantes, Josep Tabernero, Premal H. Patel, José Baselga

    Được phát hành 2013
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  9. 9
    TriTACs, a Novel Class of T-Cell–Engaging Protein Constructs Designed for the Treatment of Solid Tumors

    TriTACs, a Novel Class of T-Cell–Engaging Protein Constructs Designed for the Treatment of Solid Tumors Bằng Richard J. Austin, Bryan D. Lemon, Wade H. Aaron, Manasi Barath, Patricia Culp, Robert B. DuBridge, Luke Evnin, Adrie Jones, Anand Panchal, Purbasa Patnaik, Vanitha Ramakrishnan, Sony Sotelo Rocha, Pui Seto, Kenneth G. Sexton, Kathryn L. Strobel, Russell Wall, Stephen Yu, Timothy Z. Yu, Che‐Leung Law, Patrick A. Baeuerle, Holger Wesche

    Được phát hành 2020
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  10. 10
    Phase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myeloma

    Phase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myeloma Bằng A. Keith Stewart, Amrita Krishnan, Seema Singhal, Ralph V. Boccia, Manish R. Patel, Rubén Niesvizky, Asher Chanan‐Khan, Sikander Ailawadhi, Jochen Brumm, Kirsten Mundt, Kyu Hong, Jacqueline McBride, Quyen Shon-Nguyen, Yuanyuan Xiao, Vanitha Ramakrishnan, Andrew G. Polson, Divya Samineni, Douglas D. Leipold, Eric W. Humke, James Scott McClellan, Jesús G. Berdeja

    Được phát hành 2019
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  11. 11
    Zanubrutinib monotherapy for patients with treatment-naïve chronic lymphocytic leukemia and 17p deletion

    Zanubrutinib monotherapy for patients with treatment-naïve chronic lymphocytic leukemia and 17p deletion Bằng Constantine S. Tam, Tadeusz Robak, Paolo Ghia, Brad S. Kahl, Patricia Walker, Wojt Janowski, David Simpson, Mazyar Shadman, Peter Ganly, Luca Laurenti, Stephen Opat, Monica Tani, Hanna Ciepłuch, Emma Verner, Martin Šimkovič, Anders Österborg, Marek Trněný, Alessandra Tedeschi, Jason C. Paik, Sowmya B. Kuwahara, Shibao Feng, Vanitha Ramakrishnan, Aileen Cohen, Jane Huang, Peter Hillmen, Jennifer R. Brown

    Được phát hành 2020
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  12. 12
    Biomarker Analyses from a Placebo-Controlled Phase II Study Evaluating Erlotinib ± Onartuzumab in Advanced Non–Small Cell Lung Cancer: MET Expression Levels Are Predictive of Patient Benefit

    Biomarker Analyses from a Placebo-Controlled Phase II Study Evaluating Erlotinib ± Onartuzumab in Advanced Non–Small Cell Lung Cancer: MET Expression Levels Are Predictive of Patie... Bằng Hartmut Koeppen, Wei Yu, Jiping Zha, Ajay Pandita, Elicia Penuel, Linda Rangell, Rajiv Raja, Sankar Mohan, Rajesh Patel, Rupal Desai, Ling Fu, An Do, Vaishali Parab, Xiaoling Xia, Tom Januario, Sharianne G. Louie, Ellen Filvaroff, David S. Shames, Ignacio I. Wistuba, Marina Lipkind, Jenny Huang, Mirella Lazarov, Vanitha Ramakrishnan, Lukas C. Amler, S. Phan, Premal H. Patel, Amy Peterson, Robert L. Yauch

    Được phát hành 2014
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  13. 13
    Preclinical validation of anti-TMEFF2-auristatin E–conjugated antibodies in the treatment of prostate cancer

    Preclinical validation of anti-TMEFF2-auristatin E–conjugated antibodies in the treatment of prostate cancer Bằng Daniel Afar, Vinay Bhaskar, Eric Ibsen, Danna Breinberg, Susan M. Henshall, James G. Kench, Marija Drobnjak, Rick Powers, Melanie Wong, Ferdinand Evangelista, Chris O’hara, David B. Powers, Robert B. DuBridge, Ingrid W. Caras, Ruth Winter, Terri Anderson, Nanette Solvason, Phillip D. Stricker, Carlos Cordón-Cardo, Howard I. Scher, John J. Grygiel, Robert L. Sutherland, Richard Murray, Vanitha Ramakrishnan, Debbie A. Law

    Được phát hành 2004
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  14. 14
    DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody–Drug Conjugate, Is a Potential Treatment for Non-Hodgkin Lymphoma

    DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody–Drug Conjugate, Is a Potential Treatment for Non-Hodgkin Lymphoma Bằng Dongwei Li, Kirsten Achilles Poon, Shang‐Fan Yu, Randall C. Dere, MaryAnn Go, Jeffrey Lau, Bing Zheng, Kristi Elkins, Dimitry M. Danilenko, Katherine R. Kozak, Pamela Chan, Josefa Chuh, Xiaoyan Shi, Denise Nazzal, Franklin Fuh, Jacqueline McBride, Vanitha Ramakrishnan, Ruth de Tute, Andy C. Rawstron, Andrew Jack, Rong Deng, Yu‐Waye Chu, David Dornan, Marna Williams, William Ho, Allen Ebens, Saileta Prabhu, Andrew G. Polson

    Được phát hành 2013
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  15. 15
    A randomized, placebo-controlled trial of the BTK inhibitor zanubrutinib in hospitalized patients with COVID-19 respiratory distress: immune biomarker and clinical findings

    A randomized, placebo-controlled trial of the BTK inhibitor zanubrutinib in hospitalized patients with COVID-19 respiratory distress: immune biomarker and clinical findings Bằng Steven P. Treon, Camille N. Kotton, Jae‐Hyun Park, Giorgia Moranzoni, Camilla K. Lemvigh, Joseph Gathe, Tilly Varughese, Christopher F. Barnett, Johnny M. Belenchia, Nina M. Clark, Charles M. Farber, Muhammad Bilal Abid, Gulrayz Ahmed, Christopher J. Patterson, Maria Luisa Guerrera, Jacob D. Soumerai, Vipheaviny Chea, Isabel Carulli, Jackson Southard, Shuqiang Li, Catherine J. Wu, Kenneth J. Livak, Eric Holmgren, Pil Kim, Carrie Shi, Holly Lin, Vanitha Ramakrishnan, Ying Ou, S Olszewśki, Lars Rønn Olsen, Derin B. Keskin, Zachary R. Hunter, Chris Tankersley, Todd M. Zimmerman, Binod Dhakal

    Được phát hành 2025
    lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:

Công cụ tìm kiếm: